ION Robotic Bronchoscopy Launch 

Congratulations to Dr. Salah Aboubakr and the McLaren Greater Lansing team today on successfully conducting the first procedure using the Ion Robotic Bronchoscopy platform, a technology that provides a comprehensive solution for diagnosing and staging lung cancer.

Lung cancer is the leading cause of cancer death in the U.S., accounting for about one in five cancer deaths. With the addition of the Ion Robotic Bronchoscopy, a platform for minimally invasive peripheral lung biopsy, physicians can view deeper into the lungs and biopsy smaller, previously unreachable suspicious nodules in the peripheral tissue, allowing them to accurately diagnose the nodule as benign or cancerous and being treatment before the disease advances. 

To learn more about this state-of-the-art technology, visit https://bit.ly/4g31h4A